Galera therapeutics logo
WebFeb 15, 2024 · Galera shares, which closed Tuesday at $1.97, were recently up nearly 13%, to $2.22, in premarket trading. Write to Colin Kellaher at [email protected] Advertisement WebGalera Therapeutics, Inc. is a privately held, clinical-stage biotechnology company focused on discovering and developing novel therapeutics targeting oxygen metabolic pathways with the potential to transform how radiation therapy is used in patients with cancer. Galera’s lead product candidate is GC4419, a highly selective and potent small
Galera therapeutics logo
Did you know?
WebOct 19, 2024 · Galera Therapeutics stock plunged by more than 70% Tuesday after the Malvern biopharmaceutical firm said its lead experimental cancer therapy failed to meet its primary endpoint in late-stage ... WebAiming to Transform Outcomes for Patients With Locally Advanced Pancreatic Cancer. Pancreatic cancer incidence is rising, and this tumor is expected to become the second leading cause of cancer-related death in the United States by 2030. 7 Over 60,000 people in the United States are estimated to be diagnosed with pancreatic cancer in 2024. The 5 …
WebFeb 15, 2024 · (EDGAR Online via COMTEX) -- false 0001563577 0001563577 2024-02-15 2024-02-15 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM... WebFeb 15, 2024 · Galera Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutic candidates that have the potential to ...
WebMALVERN, Pa., March 10, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing … WebGalera Therapeutics is focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer. Website...
WebFeb 15, 2024 · Galera Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Updates. View HTML. PDF Version. Feb 15, 2024. Galera …
WebOct 21, 2024 · Galera Therapeutics, Inc. (GRTX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. how can programing be useful in lifeWebJun 12, 2024 · MALVERN, Penn., June 12, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc., a clinical-stage biotechnology company focused on the development of drugs targeting oxygen metabolic pathways with the ... how many people in the us are malnourishedWebMar 10, 2024 · Corporate Profile. We are a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutic candidates that have the potential to transform radiotherapy in cancer. Our selective dismutase mimetic product candidate avasopasem manganese (avasopasem or … how can product planners build customer valueWebGalera Therapeutics is discovering and developing novel mechanism-based therapies that have the potential to improve both treatment and outcomes for patients with cancer. … Prior to this, Dr. Beardsley was the Chief Executive Officer at Galera … Investigational Drugs – Not for Commercial Distribution Galera Market Research. Data on File. 2024; Elad S, Cheng KKF, Lalla RV, et … Galera Therapeutics is discovering and developing novel mechanism-based … Lawrence Alleva Mr. Alleva has served as a member of our Board of Directors since … Avasopasem manganese (GC4419) is an investigational selective dismutase … GRECO-2 is part of the Galera Radiotherapy Efficacy Cancer … For additional details on ongoing clinical trials, please visit www.clinicaltrials.gov. … how many people in the us are obese 2022WebFeb 15, 2024 · Mar 08, 2024. Galera Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Updates. View HTML. PDF Version. Feb 15, 2024. Galera Therapeutics Announces Pricing of Registered Direct Offering of $30 Million of Common Stock and Warrants. View HTML. PDF Version. Feb 15, 2024. how many people in the us are wealthyWebGet the latest Galera Therapeutics Inc (GRTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and … how many people in the us are named shrekWebDec 15, 2024 · Dec 15, 2024 1:48AM EST. (RTTNews) - Shares of Galera Therapeutics Inc. (GRTX) skyrocketed 95% on Tuesday, thanks to corrected results from its ROMAN trial. The ROMAN trial is a phase III study ... how can programming help the world